Related references
Note: Only part of the references are listed.Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial
Catherine A. Cluver et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure
Tomofumi Fushima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia
Feng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
SIRT1 regulates accumulation of oxidized LDL in HUVEC via the autophagy-lysosomal pathway
Yanlin Zhang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2016)
Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia
Fiona C. Brownfoot et al.
HYPERTENSION (2015)
SIRT1 attenuates PAF-induced MMP-2 production via down-regulation of PAF receptor expression in vascular smooth muscle cells
Yun H. Kim et al.
VASCULAR PHARMACOLOGY (2015)
Pre-eclampsia part 1: current understanding of its pathophysiology
Tinnakorn Chaiworapongsa et al.
NATURE REVIEWS NEPHROLOGY (2014)
Preeclampsia, a Disease of the Maternal Endothelium The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease
Camille E. Powe et al.
CIRCULATION (2011)
Angiogenic Factors and Preeclampsia
Sharon E. Maynard et al.
SEMINARS IN NEPHROLOGY (2011)
Pathogenesis of Preeclampsia
Brett C. Young et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Inflammation and pre-eclampsia
A. M. Borzychowski et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia
T Nagamatsu et al.
ENDOCRINOLOGY (2004)